United Guardian (UG) Capital Expenditures (2010 - 2026)
United Guardian's (UG) quarterly Capital Expenditures came in at $19118.0 in Q2 2026, up 8.54% year-over-year from $17613.0 in Q2 2025, and up 93.38% quarter-over-quarter from $9886.0 in Q1 2026.
Analysis
United Guardian (UG) Capital Expenditures (2010 - 2026) Analysis & Trends
United Guardian has disclosed Capital Expenditures across 17 years of filings, most recently posting $19118.0 for Q2 2026.
- In Q2 2026, Capital Expenditures rose 8.54% year-over-year to $19118.0; the TTM figure through Jun 2026 stood at $66778.0 (down 81.8% YoY), while the FY2025 annual figure was $58995.0, down 86.38% from the prior year.
- Capital Expenditures came in at $19118.0 for Q2 2026 at United Guardian, up from $9886.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $315173.0 in Q4 2024 to a low of $1330.0 in Q2 2023.
- Average Capital Expenditures over 5 years is $42331.7, with a median of $18365.5 recorded in 2025.
- Year-over-year, Capital Expenditures jumped 4813.38% in 2024 and plunged 92.85% in 2025.
- Over 5 years, Capital Expenditures stood at $15014.0 in 2022, then surged by 521.95% to $93380.0 in 2023, then soared by 237.52% to $315173.0 in 2024, then sank by 92.85% to $22539.0 in 2025, then declined by 15.18% to $19118.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $19118.0 in Q2 2026, $9886.0 in Q1 2026, and $22539.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.68 Bn | 624.92 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 441.40 Bn | 434.83 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 365.79 Bn | 358.65 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 266.44 Bn | 258.75 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Pfizer | 158.97 Bn | 147.27 Bn | 10.94 Bn | 533.00 Mn |
| 6 | Sanofi | 52.38 Bn | 45.00 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.09 Bn | 44.09 Bn | - | 2.29 Mn |
| 8 | Incyte | 25.52 Bn | 20.99 Bn | 1.57 Bn | 12.41 Mn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn | 108.00 Mn |
| 10 | United Guardian | 32.46 Mn | 22.87 Mn | 1.55 Mn | 19,118.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,118.00 |
| Mar 31, 2026 | 9,886.00 |
| Dec 31, 2025 | 22,539.00 |
| Sep 30, 2025 | 15,235.00 |
| Jun 30, 2025 | 17,613.00 |
| Mar 31, 2025 | 3,608.00 |
| Dec 31, 2024 | 315,173.00 |
| Sep 30, 2024 | 30,600.00 |
| Jun 30, 2024 | 65,348.00 |
| Mar 31, 2024 | 21,956.00 |
| Dec 31, 2023 | 93,380.00 |
| Sep 30, 2023 | 68,424.00 |
| Jun 30, 2023 | 1,330.00 |
| Mar 31, 2023 | 2,582.00 |
| Dec 31, 2022 | 15,014.00 |
| Sep 30, 2022 | 47,872.00 |
| Jun 30, 2022 | 7,453.00 |
| Mar 31, 2022 | 4,840.00 |
| Dec 31, 2021 | 34,378.00 |
| Sep 30, 2021 | 43,239.00 |